From multi-omics approaches to personalized medicine in myocardial infarction
Frontiers in Cardiovascular Medicine · 30.10.2023 · 10
DOI: 10.3389/fcvm.2023.1250340 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 30.10.2023. Verfasst von Chaoying Zhan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Si…. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 399 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Myocardial infarction (MI) is a prevalent cardiovascular disease characterized by myocardial necrosis resulting from coronary artery ischemia and hypoxia, which can lead to severe complications such as arrhythmia, cardiac rupture, heart failure, and sudden death. Despite being a research hotspot, the etiological mechanism of MI remains unclear. The emergence and widespread use of omics technologies, including genomics, transcriptomics, proteomics, metabolomics, and other omics, have provided new opportunities for exploring the molecular mechanism of MI and identifying a large number of disease biomarkers. However, a single-omics approach has limitations in understanding the complex biological pathways of diseases. The multi-omics approach can reveal the interaction network among molecules at various levels and overcome the limitations of the single-omics approaches. This review focuses on the omics studies of MI, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, and other omics. The exploration extended into the domain of multi-omics integrative analysis, accompanied by a compilation of diverse online resources, databases, and tools conducive to these investigations. Additionally, we discussed the role and prospects of multi-omics approaches in personalized medicine, highlighting the potential for improving diagnosis, treatment, and prognosis of MI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology and Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Bio-Resource and Eco-Environment of Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, China.
- Tropical Crops Genetic Resources Institute, Chinese Academy of Tropical Agricultural Sciences, Haikou, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhan, C., Tang, T., Wu, E., Zhang, Y., He, M., Wu, R., Bi, C., Wang, J., Zhang, Y., & Shen, B. (2023). From multi-omics approaches to personalized medicine in myocardial infarction. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1250340
Vancouver
Zhan C, Tang T, Wu E, Zhang Y, He M, Wu R, et al. From multi-omics approaches to personalized medicine in myocardial infarction. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1250340
BibTeX
@article{Zhan2023,
author = {Zhan, Chaoying and Tang, Tong and Wu, Erman and Zhang, Yuxin and He, Mengqiao and Wu, Rongrong and Bi, Cheng and Wang, Jiao and Zhang, Yingbo and Shen, Bairong},
title = {From multi-omics approaches to personalized medicine in myocardial infarction},
journal = {Frontiers in Cardiovascular Medicine},
year = {2023},
volume = {10},
doi = {10.3389/fcvm.2023.1250340}
}
EUVIMED